Advertisement

Related Videos

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Advertisement

Advertisement




Jun
23
Today In Oncology
Subgroup Analysis Demonstrates Efficacy of Inavolisib Regimen in Asian Patients With Advanced Breast Cancer
GLP-1 Receptor Agonists Linked to Lower Colorectal Cancer Risk in Patients With IBD
Chinese Study of HER2-Targeted Combination Therapy for Locally Advanced Breast Cancer
Multi-Cancer Early Detection Test Performs Well in Real-World Asian Cohort
Early Palliative Care Improves Quality of Life for Patients With Breast Cancer in India
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo